Du Y, Qi Z, Liang X, Dai J, Wei X, Bai X, et al. Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study . Dermatol Pract Concept [Internet]. 2024 Jan. 31 [cited 2026 Apr. 19];14(1):e2024026. Available from: https://dpcj.org/index.php/dpc/article/view/3517